These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
873 related articles for article (PubMed ID: 28418232)
21. Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study. Jalil EM; Torres TS; Luz PM; Monteiro L; Moreira RI; de Castro CRV; Leite IDC; Cunha M; de Cássia Elias Estrela R; Ramos M; Hoagland B; Wagner Cardoso S; Anderson P; Veloso VG; Wilson E; Grinsztejn B; J Int AIDS Soc; 2022 Mar; 25(3):e25896. PubMed ID: 35255199 [TBL] [Abstract][Full Text] [Related]
22. Factors associated with self-reported adherence to daily oral pre-exposure prophylaxis among men who have sex with man and transgender women: PrEP Brasil study. Monteiro Spindola Marins L; Silva Torres T; Luz PM; Moreira RI; Leite IC; Hoagland B; Kallas EG; Madruga JV; Grinsztejn B; Veloso VG; Int J STD AIDS; 2021 Nov; 32(13):1231-1241. PubMed ID: 34311605 [TBL] [Abstract][Full Text] [Related]
23. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study. Molina JM; Ghosn J; Assoumou L; Delaugerre C; Algarte-Genin M; Pialoux G; Katlama C; Slama L; Liegeon G; Beniguel L; Ohayon M; Mouhim H; Goldwirt L; Spire B; Loze B; Surgers L; Pavie J; Lourenco J; Ben-Mechlia M; Le Mestre S; Rojas-Castro D; Costagliola D; Lancet HIV; 2022 Aug; 9(8):e554-e562. PubMed ID: 35772417 [TBL] [Abstract][Full Text] [Related]
24. HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project. Sullivan PS; Phaswana-Mafuya N; Baral SD; Valencia R; Zahn R; Dominguez K; Yah CS; Jones J; Kgatitswe LB; McNaghten AD; Siegler AJ; Sanchez TH; Bekker LG J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25591. PubMed ID: 33000918 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens. Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660 [TBL] [Abstract][Full Text] [Related]
26. Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam's first pre-exposure prophylaxis program. Green KE; Nguyen LH; Phan HTT; Vu BN; Tran MH; Ngo HV; Tieu VTT; Van H; Le TM; Do KQ; Nguyen PA; Ngo TM; Doan AH; Bui DTN; Nguyen TNN; Hang LTX; Tran TT; Luong BQ Sex Health; 2021 Mar; 18(1):104-115. PubMed ID: 33653505 [TBL] [Abstract][Full Text] [Related]
27. Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trial. Goldwirt L; Bauer R; Liegeon G; Charreau I; Delaugerre C; Cotte L; Pialou G; Cua E; Laghzal A; Buschman L; Anderson PL; Mourah S; Meyer L; Molina JM; J Antimicrob Chemother; 2021 Sep; 76(10):2675-2680. PubMed ID: 34278433 [TBL] [Abstract][Full Text] [Related]
28. Demonstration project of oral TDF-containing PrEP, administered, once-daily orally to men having sex with men (MSM) and transgender women (TGW) in India: Study protocol. Sahay S; Bangar S; Chandhiok N PLoS One; 2023; 18(6):e0287454. PubMed ID: 37352188 [TBL] [Abstract][Full Text] [Related]
29. Concordance between daily diary reported pre-exposure prophylaxis intake and intraerythrocytic tenofovir diphosphate in the Amsterdam Pre-exposure Prophylaxis demonstration project. Wijstma ES; Jongen VW; Boyd A; van den Elshout MAM; de Vries HJC; Davidovich U; Anderson PL; Prins M; Hoornenborg E; Schim van der Loeff MF AIDS; 2024 Jul; 38(8):1248-1256. PubMed ID: 38518076 [TBL] [Abstract][Full Text] [Related]
30. Recent HIV Risk Behavior and Partnership Type Predict HIV Pre-Exposure Prophylaxis Adherence in Men Who Have Sex with Men. Blumenthal J; Moore DJ; Jain S; Sun X; Ellorin E; Corado K; Hoenigl M; Dube M; Haubrich R; Morris SR AIDS Patient Care STDS; 2019 May; 33(5):220-226. PubMed ID: 31067122 [TBL] [Abstract][Full Text] [Related]
31. Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing. Spinelli MA; Glidden DV; Anderson PL; Gandhi M; Cohen S; Vittinghoff E; Coleman ME; Scott H; Bacon O; Elion R; Kolber MA; Buchbinder SP; Liu AY J Acquir Immune Defic Syndr; 2019 Jun; 81(2):158-162. PubMed ID: 31095005 [TBL] [Abstract][Full Text] [Related]
32. Feasibility, Acceptability, and Adherence with Short-Term HIV Preexposure Prophylaxis in Female Sexual Partners of Migrant Miners in Mozambique. Lahuerta M; Zerbe A; Baggaley R; Falcao J; Ahoua L; DiMattei P; Morales F; Ramiro I; El-Sadr WM J Acquir Immune Defic Syndr; 2017 Dec; 76(4):343-347. PubMed ID: 28777264 [TBL] [Abstract][Full Text] [Related]
33. Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men. Shieh E; Marzinke MA; Fuchs EJ; Hamlin A; Bakshi R; Aung W; Breakey J; Poteat T; Brown T; Bumpus NN; Hendrix CW J Int AIDS Soc; 2019 Nov; 22(11):e25405. PubMed ID: 31692269 [TBL] [Abstract][Full Text] [Related]
34. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM; Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343 [TBL] [Abstract][Full Text] [Related]
35. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study. Tapsoba JD; Cover J; Obong'o C; Brady M; Cressey TR; Mori K; Okomo G; Kariithi E; Obanda R; Oluoch-Madiang D; Chen YQ; Drain P; Duerr A PLoS Med; 2022 Sep; 19(9):e1004097. PubMed ID: 36095005 [TBL] [Abstract][Full Text] [Related]
36. Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report. Hoornenborg E; Prins M; Achterbergh RCA; Woittiez LR; Cornelissen M; Jurriaans S; Kootstra NA; Anderson PL; Reiss P; de Vries HJC; Prins JM; de Bree GJ; Lancet HIV; 2017 Nov; 4(11):e522-e528. PubMed ID: 28919303 [TBL] [Abstract][Full Text] [Related]
37. An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM. Hosek SG; Rudy B; Landovitz R; Kapogiannis B; Siberry G; Rutledge B; Liu N; Brothers J; Mulligan K; Zimet G; Lally M; Mayer KH; Anderson P; Kiser J; Rooney JF; Wilson CM; J Acquir Immune Defic Syndr; 2017 Jan; 74(1):21-29. PubMed ID: 27632233 [TBL] [Abstract][Full Text] [Related]
38. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. Laurent C; Dembélé Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traoré I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fayé-Ketté H; Koné A; Diandé S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B; Lancet HIV; 2021 Jul; 8(7):e420-e428. PubMed ID: 34048794 [TBL] [Abstract][Full Text] [Related]
39. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial. Celum C; Hosek S; Tsholwana M; Kassim S; Mukaka S; Dye BJ; Pathak S; Mgodi N; Bekker LG; Donnell DJ; Wilson E; Yuha K; Anderson PL; Agyei Y; Noble H; Rose SM; Baeten JM; Fogel JM; Adeyeye A; Wiesner L; Rooney J; Delany-Moretlwe S PLoS Med; 2021 Jun; 18(6):e1003670. PubMed ID: 34143779 [TBL] [Abstract][Full Text] [Related]
40. Correlates of nonadherence to key population-led HIV pre-exposure prophylaxis services among Thai men who have sex with men and transgender women. Seekaew P; Nguyen E; Sungsing T; Jantarapakde J; Pengnonyang S; Trachunthong D; Mingkwanrungruang P; Sirisakyot W; Phiayura P; Panpet P; Meekrua P; Praweprai N; Suwan F; Sangtong S; Brutrat P; Wongsri T; Nakorn PRN; Mills S; Avery M; Vannakit R; Phanuphak P; Phanuphak N BMC Public Health; 2019 Mar; 19(1):328. PubMed ID: 30898095 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]